Hengrui's 2025 annual report says the company vigorously develops AI-driven drug discovery, which it abbreviates AIDD, and that AI technology is deeply integrated throughout its R&D pipeline.
Source
Company Archive pending
Hengrui's 2025 annual report says the company vigorously develops AI-driven drug discovery, which it abbreviates AIDD, and that AI technology is deeply integrated throughout its R&D pipeline.